Concepedia

Efficacy and Tolerability of Once-Daily Therapy with Telithromycin for 5 or 10 Days for the Treatment of Acute Maxillary Sinusitis

Kees-Peter de Roos, C. Brunswig-Pitschner, Rom Kostřica, Matti Pietola, Bruno Leroy, Manickam Rangaraju, Y. Boutalbi

Chemotherapy · 2002 · 66 citations · 16 references

DOI

Abstract

A 5-day course of telithromycin 800 mg once daily is an effective, well-tolerated treatment for adults with AMS, comparable to a 10-day regimen.

References

16

Current estimates from the National Health Interview Survey.

Jack Ss · PubMed · 1981 · 1.9K citations

, , +3

Low Dosage and Long Treatment Duration of β-Lactam

Didier Guillemot, Claude Carbón, Beverley Balkau et al. · JAMA · 1998 · 554 citations

, , +16

The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections

D. Felmingham, R. N. Grüneberg · Journal of Antimicrobial Chemotherapy · 2000 · 368 citations · Full text

Susceptibilities of <i>Streptococcus pneumoniae</i> and <i>Haemophilus influenzae</i> to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance Study

Michael R. Jacobs, Saralee Bajaksouzian, Anne Zilles et al. · Antimicrobial Agents and Chemotherapy · 1999 · 317 citations · Full text

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998

Clyde Thornsberry, Mark E. Jones, Mary L. Hickey et al. · Journal of Antimicrobial Chemotherapy · 1999 · 301 citations · Full text